Finucane CM - Search Results

1

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.

Wythe SE, DiCara D, Taher TE, Finucane CM, Jones R, Bombardieri M, Man YK, Nissim A, Mather SJ, Chernajovsky Y, Pitzalis C. Wythe SE, et al. Among authors: finucane cm. Ann Rheum Dis. 2013 Jan;72(1):129-35. doi: 10.1136/annrheumdis-2012-201457. Epub 2012 Jul 27. Ann Rheum Dis. 2013. PMID: 22843486 Free PMC article.

2

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.

Kamperidis P, Kamalati T, Ferrari M, Jones M, Garrood T, Smith MD, Diez-Posada S, Hughes C, Finucane C, Mather S, Nissim A, George AJ, Pitzalis C. Kamperidis P, et al. Arthritis Rheum. 2011 Dec;63(12):3758-67. doi: 10.1002/art.30650. Arthritis Rheum. 2011. PMID: 21953304 Free article.

3

Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide.

Sosabowski JK, Matzow T, Foster JM, Finucane C, Ellison D, Watson SA, Mather SJ. Sosabowski JK, et al. J Nucl Med. 2009 Dec;50(12):2082-9. doi: 10.2967/jnumed.109.064808. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910426 Free article.

4

Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies.

Finucane CM, Murray I, Sosabowski JK, Foster JM, Mather SJ. Finucane CM, et al. Int J Mol Imaging. 2011;2011:197381. doi: 10.1155/2011/197381. Epub 2011 Mar 16. Int J Mol Imaging. 2011. PMID: 21603236 Free PMC article.

5

99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.

King R, Surfraz MB, Finucane C, Biagini SC, Blower PJ, Mather SJ. King R, et al. J Nucl Med. 2009 Apr;50(4):591-8. doi: 10.2967/jnumed.108.058289. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289435 Free article.

6

Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo.

Naqvi SA, Matzow T, Finucane C, Nagra SA, Ishfaq MM, Mather SJ, Sosabowski J. Naqvi SA, et al. Cancer Biother Radiopharm. 2010 Feb;25(1):89-95. doi: 10.1089/cbr.2009.0666. Cancer Biother Radiopharm. 2010. PMID: 20187801

7

High-throughput high-volume nuclear imaging for preclinical in vivo compound screening^§.

Macholl S, Finucane CM, Hesterman J, Mather SJ, Pauplis R, Scully D, Sosabowski JK, Jouannot E. Macholl S, et al. Among authors: finucane cm. EJNMMI Res. 2017 Dec;7(1):33. doi: 10.1186/s13550-017-0281-4. Epub 2017 Apr 7. EJNMMI Res. 2017. PMID: 28389883 Free PMC article.

8

Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases.

Torres Martin de Rosales R, Finucane C, Mather SJ, Blower PJ. Torres Martin de Rosales R, et al. Chem Commun (Camb). 2009 Aug 28;(32):4847-9. doi: 10.1039/b908652h. Epub 2009 Jul 14. Chem Commun (Camb). 2009. PMID: 19652801 Free PMC article.

9

Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.

Pujatti PB, Foster JM, Finucane C, Hudson CD, Burnet JC, Pasqualoto KFM, Mengatti J, Mather SJ, de Araújo EB, Sosabowski JK. Pujatti PB, et al. Appl Radiat Isot. 2015 Feb;96:91-101. doi: 10.1016/j.apradiso.2014.11.006. Epub 2014 Nov 11. Appl Radiat Isot. 2015. PMID: 25479439

10

188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases.

Torres Martin de Rosales R, Finucane C, Foster J, Mather SJ, Blower PJ. Torres Martin de Rosales R, et al. Bioconjug Chem. 2010 May 19;21(5):811-5. doi: 10.1021/bc100071k. Bioconjug Chem. 2010. PMID: 20387897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters